medigraphic.com
SPANISH

Revista del Hospital Juárez de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 2

<< Back Next >>

Rev Hosp Jua Mex 2012; 79 (2)

Enfermedad de Addison en un adolescente masculino

Narváez-Casillas VE, Vargas-Hernández A
Full text How to cite this article

Language: Spanish
References: 10
Page: 119-124
PDF size: 378.72 Kb.


Key words:

Addison’s disease, autoinmune, suprarenal bark, autoimmune poliglandular syndromes.

ABSTRACT

Introduction. The Addison’s disease is a pathology of slow and progressive evolution, caused by the insufficient offer of hormones corticosuprarrenales to the habitual demands of the organism that have their origin in the bilateral destruction of the suprarenal bark. It is difficult to understand today the Addison’s disease but it is in the context of the autoimmune poliglandular syndromes, given the frequent association with other endocrinopathies. Objective. To describe the case of a 15 year-old boy, with Addison’s disease of autoimmune ethiology, since a low incidence is reported and especially in the pediatric age of 0.83 cases for 100,000 inhabitants a year. Case report. Masculine patient of 15 years of age, which began 2 years ago with hiperpigmentation in teguments and lost of weight with little gain ponderal, one year ago with widespread weakness, asthenia, adinamia, emotional labilidad, with avidity for the salt, sintomathology that is exacerbated in the month of January 2007 with anorexy, sicknesses, you nauseate without arriving to the vomit, migraine, vertigo and important abdominal pain, managed for half particular as peptic illness acid without improvement. Conclusion. The Addison’s disease of autoimmune ethiology is not very frequent in pediatric stages, a high index of suspicion is required for its diagnosis and to begin a substitute opportune treatment.


REFERENCES

  1. Kannan CR. The Addison’s disease in the adrenal gland. Ed. Plenum Medica; 1988: 31-96.

  2. Liddle G. Enfermedades de la corteza suprarrenal. In: Williams. Tratado de Endocrinología. 6a. ed. 1985, p. 295.

  3. Zamora Madaria E, Mangas Rojas A. Enfermedades de la corteza suprarrenal. En: Díaz-Rubio E. Tratado de Medicina Interna. Interamericana 1994, p. 2411-25.

  4. Oelkers W. Adrenal insufficiency. Current-concepts. N Engl J Med 1996; 335: 1206-12.

  5. Burke C. Enfermedades corticosuprarrenales. En: Weatherall D, Ledigham J, Warrell D. Tratado de Medicina Interna. Oxford: Ed. Folium; 1993; 2: 10.82-10.86.

  6. Martínez Albaladejo M, García López B, Serrano Corredor S, Alguacil García G. Masa suprarrenal e insuficiencia suprarrenal. An Med Interna (Madrid) 1996; 3(2): 595-7.

  7. Villabona CM, Sahun M, Ricart N, Serres X, Maroto A, Fernández Real JM, et al. Tuberculous Addison’s disease. Utility of CT in diagnosis and follow-up. Eur J Radiol 1993; 17: 210-3.

  8. Vita J, Silverberg S, Goland R, Austin M, Knowlton A. Clinical clues to the cause of Addison's disease. Am J Med 1985; 78: 461-6.

  9. Aron DC. Endocrine complications of the adquired inmunodeficiency syndrom. Arch Intern Med 1989; 149: 330.

  10. Oelkers W, Diederich S, Bähr V. Recent advances in diagnosis and therapy of Addison’s disease. In: Bhatt M, James VHT, Besser GM et al. Advances in Thomas Addison’s Diseases. J Endocrinolgy Thomas Addison’s Society 2004; 1: 69-80.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hosp Jua Mex. 2012;79